Advertisement

Canadian Journal of Public Health

, Volume 91, Issue 2, pp 103–106 | Cite as

The Costs of Cardiorespiratory Disease Episodes in a Study of Emergency Department Use

  • Aslam H. AnisEmail author
  • Daphne Guh
  • David Stieb
  • Hector Leon
  • Robert C. Beveridge
  • Richard T. Burnett
  • Robert E. Dales
Article

Abstract

Objective: The average per person direct cost of illness of cardiorespiratory disease episodes was estimated based on a prospective study of emergency department visits.

Methods: Economic modelling of health care costs using prospectively collected resource utilization data (9/1/94 to 8/31/95) from hospital emergency department visitors assigned a diagnosis of asthma, chronic obstructive pulmonary disease (COPD), respiratory infections or cardiac conditions.

Results: The total direct costs (1997 CDN$) [95% C.I.] per patient were $1,043.55 [$922.65, $1,164.47] for asthma, $1,690.11 [$1,276.92, $2,103.30] for COPD, $676.50 [$574.46, $778.54] for respiratory infections, and $3,318.74 [$2,937.72, $3,699.76] for cardiac conditions.

Conclusions: This study showed that on average, patients diagnosed with a cardiac condition had the highest total direct cost. Hospitalization cost was the largest component of costs for all diagnoses except asthma, for which medications were the single largest component of direct costs.

Résumé

Objectif: Le coût direct moyen par personne des épisodes de maladies cardiorespiratoires a été évalué en fonction d’une étude prospective des visites au service des urgences.

Méthodes: Établissement de modèles économiques des coûts relatifs aux soins médicaux d’après des données sur l’utilisation des ressources recueillies prospectivement (du 1er septembre 1994 au 31 août 1995) de services des urgences d’hôpitaux au sujet de patients ayant les diagnostics suivants: asthme, bronchopneumopathie chronique obstructive (BCO), infections respiratoires ou maladies cardiaques.

Résultats: Les coûts directs totaux ($CAN 1997) [IC de 95 % ] par patient étaient de 1 043,55 $ [922,65 $, 1 164,47 $] pour l’asthme, de 1 690,11 $ [1 276,92 $, 2 103,30 $] pour les cas de BCO, de 676,50 $ [574,46 $, 778,54 $] pour les infections respiratoires, et de 3 318,74 $ [2 937,72 $, 3 699,76 $] pour les maladies cardiaques.

Conclusions: Cette étude montre qu’en moyenne, les coûts directs totaux sont plus élevés pour les patients atteints d’une maladie cardiaque. Les coûts d’hospitalisation représentaient la principale part des coûts directs pour tous les diagnostics à l’exception de l’asthme où le coût des médicaments était le plus important.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Stieb DM, Beveridge RC, Smith-Doiron M, et al. Beyond administrative data: Characterizing cardiorespiratory disease episodes among patients visiting the emergency department. Can J Public Health 2000;91(2):107–12.PubMedGoogle Scholar
  2. 2.
    Bates DV, Sizto R. The relationship between air pollutant levels and hospital admissions in southern Ontario. Can J Public Health 1983;74:117–22.PubMedGoogle Scholar
  3. 3.
    Burnett RT, Dales RE, Raizenne ME, et al. Effects of low ambient levels of ozone and sulfates on the frequency of respiratory admissions to Ontario hospitals. Environ Res 1994;65:172–94.CrossRefGoogle Scholar
  4. 4.
    Burnett RT, Dales R, Krewski D, et al. Associations between ambient particulate sulfate and admissions to Ontario hospitals for cardiac and respiratory diseases. Am J Epidemiol 1995;142(1):15–22.CrossRefGoogle Scholar
  5. 5.
    Burnett RT, Dales RE, Brook JR, et al. Association between ambient carbon monoxide levels and hospitalizations for congestive heart failure in the elderly in 10 Canadian cities. Epidemiology 1997;8(2):162–67.CrossRefGoogle Scholar
  6. 6.
    Burnett RT, Brook JR, Yung WT, et al. Association between ozone and hospitalization for respiratory diseases in 16 Canadian cities. Environ Res 1997;72:24–31.CrossRefGoogle Scholar
  7. 7.
    Schwartz J. Particulate air pollution and hospital emergency room visits for asthma in Seattle. Am Rev Respir Dis 1993;147:826–31.CrossRefGoogle Scholar
  8. 8.
    Romieu I, Meneses F, Sienra-Monge JJ, et al. Effects of urban air pollutants on emergency visits for childhood asthma in Mexico City. Am J Epidemiol 1995;141:546–53.CrossRefGoogle Scholar
  9. 9.
    Sunyer J, Anto JM, Murillo C, Saez M. Effects of urban air pollution on emergency room admissions for chronic obstructive pulmonary disease. Am J Epidemiol 1991;134:277–86.CrossRefGoogle Scholar
  10. 10.
    Weisel CP, Cody RP, Lioy, PL. Relationship between summertime ambient ozone levels and emergency department visits for asthma in central New Jersey. Environ Health Perspect 1995;103(Suppl 2):97–102.PubMedPubMedCentralGoogle Scholar
  11. 11.
    White MC, Etzel RA, Wilcox WD, et al. Exacerbations of childhood asthma and ozone pollution in Atlanta. Environ Res 1994;65:56–68.CrossRefGoogle Scholar
  12. 12.
    Jones GN, Sletten C, Mandry C, et al. Ozone level effect on respiratory illness: An investigation of emergency department visits. South Med J 1995;88(10):1049–56.CrossRefGoogle Scholar
  13. 13.
    Castellsague J, Sunyer J, Saez M, et al. Shortterm association between air pollution and emergency room visits for asthma in Barcelona. Thorax 1995;50:1051–56.CrossRefGoogle Scholar
  14. 14.
    Bates DV, Baker-Anderson M, Sizto R. Asthma attack periodicity: A study of hospital emergency visits in Vancouver. Environ Res 1990;51:51–70.CrossRefGoogle Scholar
  15. 15.
    Delfino RJ, Murphy-Moulton AM, Burnett RT, et al. Effects of air pollution on emergency room visits for respiratory illnesses in Montreal, Quebec. Am J Respir Crit Care Med 1997;155:568–76.CrossRefGoogle Scholar
  16. 16.
    Stieb DM, Burnett RT, Beveridge RC, et al. Association between ozone and asthma emergency department visits in Saint John, New Brunswick, Canada. Environ Health Perspect 1996;104(12):1354–60.CrossRefGoogle Scholar
  17. 17.
    Statistics Canada: Consumer Price Index (All Products). Cat. 62-533.1997.Google Scholar
  18. 18.
    Canadian Pharmaceutical Association. Compendium of Pharmaceuticals and Specialties. Thirty-first Edition. Ottawa: CPhA, 1996.Google Scholar
  19. 19.
    Stewart D. St. Paul’s Hospital Cost Model–1994/95.Google Scholar
  20. 20.
    Drummond MF, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press, 1987.Google Scholar

Copyright information

© The Canadian Public Health Association 2000

Authors and Affiliations

  • Aslam H. Anis
    • 1
    • 2
    Email author
  • Daphne Guh
    • 1
    • 2
  • David Stieb
    • 3
  • Hector Leon
    • 1
    • 2
  • Robert C. Beveridge
    • 4
  • Richard T. Burnett
    • 3
  • Robert E. Dales
    • 3
  1. 1.Centre for Health Evaluation and Outcome SciencesSt. Paul’s HospitalVancouverCanada
  2. 2.Department of Health Care and EpidemiologyUniversity of British ColumbiaCanada
  3. 3.Environmental Health DirectorateHealth CanadaCanada
  4. 4.Department of Emergency MedicineAtlantic Health Sciences CorporationCanada

Personalised recommendations